Cargando…

Cellular and Molecular Mechanisms Underlying Liver Fibrosis Regression

Chronic liver injury of different etiologies may result in hepatic fibrosis, a scar formation process consisting in altered deposition of extracellular matrix. Progression of fibrosis can lead to impaired liver architecture and function, resulting in cirrhosis and organ failure. Although fibrosis wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caligiuri, Alessandra, Gentilini, Alessandra, Pastore, Mirella, Gitto, Stefano, Marra, Fabio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534788/ https://www.ncbi.nlm.nih.gov/pubmed/34685739 http://dx.doi.org/10.3390/cells10102759

Ejemplares similares

Oncostatin M: From Intracellular Signaling to Therapeutic Targets in Liver Cancer
por: Caligiuri, Alessandra, et al.
Publicado: (2022)

Molecular Pathogenesis of NASH
por: Caligiuri, Alessandra, et al.
Publicado: (2016)

Role of Chemokines in the Biology of Cholangiocarcinoma
por: Caligiuri, Alessandra, et al.
Publicado: (2020)

The Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor Epithelium
por: Gentilini, Alessandra, et al.
Publicado: (2018)

Evaluation of intracellular signalling pathways in response to insulin-like growth factor I in apoptotic-resistant activated human hepatic stellate cells
por: Gentilini, Alessandra, et al.
Publicado: (2009)

The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells
por: Di Maira, Giovanni, et al.
Publicado: (2019)

Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives
por: Pastore, Mirella, et al.
Publicado: (2020)

Mechanisms Underlying Cell Therapy in Liver Fibrosis: An Overview
por: Pinheiro, Daphne, et al.
Publicado: (2019)

From advanced disease to transplantation: an overview of the liver at the time of COVID-19 pandemic
por: Vitale, Giovanni, et al.
Publicado: (2021)

Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis
por: Strippoli, Raffaele, et al.
Publicado: (2016)

Molecular and cellular mechanisms of pulmonary fibrosis
por: Todd, Nevins W, et al.
Publicado: (2012)

Cellular and Molecular Mechanisms of Intestinal Fibrosis
por: Wu, Xiaomin, et al.
Publicado: (2023)

Cellular and Molecular Mechanisms of Liver Fibrosis in Patients with NAFLD
por: Sanchez, Jessica I., et al.
Publicado: (2023)

Cellular and Molecular Mechanisms in Idiopathic Pulmonary Fibrosis
por: Zhang, Yihang, et al.
Publicado: (2023)

Endometriosis: Cellular and Molecular Mechanisms Leading to Fibrosis
por: Garcia Garcia, Jose Manuel, et al.
Publicado: (2022)

Alcohol use disorder and liver transplant: new perspectives and critical issues
por: Gitto, Stefano, et al.
Publicado: (2020)

Cellular Mechanisms of Liver Fibrosis
por: Acharya, Pragyan, et al.
Publicado: (2021)

Regression of liver fibrosis: evidence and challenges
por: Sun, Ya-Meng, et al.
Publicado: (2020)

Combatting Fibrosis: Exosome‐Based Therapies in the Regression of Liver Fibrosis
por: Chen, Li, et al.
Publicado: (2018)

Histopathological evaluation of liver fibrosis and cirrhosis regression
por: Lo, Regina C., et al.
Publicado: (2017)

A review of liver fibrosis and cirrhosis regression
por: Lee, Michael J.
Publicado: (2023)

Special Issue on “Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis”
por: Weiskirchen, Ralf
Publicado: (2020)

A review of current studies on cellular and molecular mechanisms underlying pulmonary fibrosis induced by chemicals
por: Kim, Ha Ryong, et al.
Publicado: (2018)

Cellular senescence primes liver fibrosis regression through Notch‐EZH2
por: Song, Ping, et al.
Publicado: (2023)

Recent Advancements in Antifibrotic Therapies for Regression of Liver Fibrosis
por: Jangra, Anshika, et al.
Publicado: (2022)

Cellular and molecular mechanisms underlying muscular dystrophy
por: Rahimov, Fedik, et al.
Publicado: (2013)

Cellular and molecular mechanisms underlying presynapse formation
por: Chia, Poh Hui, et al.
Publicado: (2013)

Special Issue on “Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II”
por: Weiskirchen, Ralf
Publicado: (2022)

Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome after Liver Transplant
por: Gitto, Stefano, et al.
Publicado: (2016)

Molecular Mechanisms of Liver Fibrosis in HIV/HCV Coinfection
por: Mastroianni, Claudio M., et al.
Publicado: (2014)

Cellular and molecular mechanisms in COVID-19 coagulopathy: role of inflammation and endotheliopathy
por: Cacciola, Rossella, et al.
Publicado: (2021)

Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
por: Guo, Tiantian, et al.
Publicado: (2020)

Macrophage MerTK promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators
por: Pastore, Mirella, et al.
Publicado: (2022)

Extracellular Signal‐Regulated Kinase 5 Regulates the Malignant Phenotype of Cholangiocarcinoma Cells
por: Gentilini, Alessandra, et al.
Publicado: (2021)

Molecular Mechanisms and Cellular Contribution from Lung Fibrosis to Lung Cancer Development
por: Samarelli, Anna Valeria, et al.
Publicado: (2021)

Molecular Mechanism and Treatment of Viral Hepatitis-Related Liver Fibrosis
por: Su, Tung-Hung, et al.
Publicado: (2014)

Molecular Mechanisms That Link Oxidative Stress, Inflammation, and Fibrosis in the Liver
por: Ramos-Tovar, Erika, et al.
Publicado: (2020)

The Molecular Mechanisms of Liver Fibrosis and Its Potential Therapy in Application
por: Zhang, Danyan, et al.
Publicado: (2022)

Liver Fibrosis Resolution: From Molecular Mechanisms to Therapeutic Opportunities
por: Pei, Qiying, et al.
Publicado: (2023)

Emerging cellular and molecular mechanisms underlying anticancer indications of chrysin
por: Talebi, Marjan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uuj3csui40qglj4vjc1lvdt6ng